The result of NGS was reported on day 58, and the NGS identified a CCDC6-RET fusion (C1; R12) with no other reported genomic alterations known to contribute to human breast tumorigenesis, including none in BRCA1 or BRCA2. CTNNB1 M739I, KEL R14H, MET L211W, and MTOR R2110Q were detected as variants of unknown significance in the patient’s tumor. The gene discussed is RET; the disease is neoplasm.